FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer
Romain‐David Seban, Jean‐Baptiste Assié, Etienne Giroux‐Leprieur, Marie-Ange Massiani, Michaël Soussan, G. Bonardel, C. Chouaïd, Margot Playe, Lucas Goldfarb, Boris Duchemann, Nicolas Girard, Laurence Champion
Topics & Concepts
MedicineInternal medicineLung cancerOncologyPembrolizumabProportional hazards modelImmunotherapyMultivariate analysisProgression-free survivalCancerOverall survivalCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentRadiomics and Machine Learning in Medical Imaging